CLINICAL TRIAL

questionnaires for Leukemia

Waitlist Available · 18+ · All Sexes · New York, NY

This study is evaluating whether a diet and exercise program can help people lose weight.

See full description

About the trial for Leukemia

Eligible Conditions
Adult Survivors of Childhood Leukemia · Leukemia

Treatment Groups

This trial involves 2 different treatments. Questionnaires is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Main TreatmentA portion of participants receive this new treatment to see if it outperforms the control.
individual diet & physical activity counselor and website through Healthways at Hopkins
BEHAVIORAL
questionnaires
BEHAVIORAL
fasting blood draw, measurement of height, weight and waist circumference, and blood pressure
OTHER
Control TreatmentAnother portion of participants receive the standard treatment to act as a baseline.
questionnaires
BEHAVIORAL
self directed weight loss
BEHAVIORAL
fasting blood draw, measurement of height, weight and waist circumference, and blood pressure
OTHER

About The Treatment

Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
questionnaires
2008
Completed Phase 4
~3200

Eligibility

This trial is for patients born any sex aged 18 and older. There are 8 eligibility criteria to participate in this trial as listed below.

Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:
People who want to use EQUAL will have to answer a few questions on a website to see if they are eligible show original
, was associated with increased odds of hypertension, compared with BMI < 25 kg/m2 (normal weight), in both men and women show original
The person enrolled in the study is cancer free at the time of enrollment. show original
are now required by most employers Most employers now require their employees to have internet access and a personal email account. show original
Participation in the CCSS cohort
The person has been diagnosed with a type of leukemia that occurs most often in young people. show original
Current age ≥ 18 years
forms Can read and understand information in consent forms. show original
View All
Odds of Eligibility
Unknown<50%
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial
Similar Trials

Approximate Timelines

Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: 24 months
Screening: ~3 weeks
Treatment: Varies
Reporting: 24 months
This trial has approximate timelines as follows: 3 weeks for initial screening, variable treatment timelines, and reporting: 24 months.
View detailed reporting requirements
Trial Expert
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like

Measurement Requirements

This trial is evaluating whether questionnaires will improve 1 primary outcome in patients with Leukemia. Measurement will happen over the course of 24 months.

Weight loss
24 MONTHS
Weight loss will be evaluated in an intent-to-treat analysis with a linear mixed effects model with robust standard errors and an unstructured covariance matrix(50) using weight measured at each time points (0, 12 months and 24 months after randomization) as the outcome modeled as a function of time, randomization arm, a history of CRT, gender, age, and race together with interaction terms between time and randomization arm.
24 MONTHS

Patient Q & A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is questionnaires safe for people?

It might not be possible to use questionnaires like these in the context of an illness. For example, patients receiving steroids, which have the potential to interfere with neuropsychological instruments, might be a problem.

Anonymous Patient Answer

What are common treatments for leukemia?

Targeted therapy is used in a variety of adult and pediatric leukemia cases. Common forms of targeted therapy include tyrosine kinase inhibitors and anthracycline or platinum-based drugs. More advanced cases may involve more advanced drug regimens or combination therapy.

Anonymous Patient Answer

Can leukemia be cured?

Patients with chronic myeloid leukemia will probably be cured if they have a complete remission of the disease. However, patients with B-cell precursors of acute myelogenous leukemia will not be cured, since relapse will probably occur. Patients with acute myelogenous leukemia, a subtype of B-cell precursors, may be affected (relapse) if they do not receive treatment. The effect of cancer therapies on chronic myelogenous leukemia remains uncertain.

Anonymous Patient Answer

What are the signs of leukemia?

Signs of leukemia appear similar in each leukemia subtype and all patients are at increased risk because all cases may contain only one sign of leukemia. If the signs of leukemia are not present, other symptoms such as fatigue, unintentional weight loss, fever, malaise, and dizziness should be followed up in order to find signs of leukemia and monitor patient response to treatment.

Anonymous Patient Answer

What causes leukemia?

leukemias and other cancers share some of the same inherited predisposition and risk factors. The occurrence of leukemias may be influenced in part by environmental factors including the use of carcinogens or viral infection. Other risk factors include an underlying genetic defect like familial leukemia, and environmental exposures to ionizing radiation and chemicals.

Anonymous Patient Answer

How many people get leukemia a year in the United States?

Around 20,300 cases of acute myeloid leukemia (AML) and 1,400 cases of acute lymphocytic leukemia (ALL) occur each year in adults. For children, AML accounted for 20,300 cases and ALL for 1,240 cases.

Anonymous Patient Answer

What is leukemia?

Leukemia is a type of cancer that forms in the white blood cells, the bone marrow and the platelets, and is caused by abnormal cells arising from the hematopoietic stem cells in the bone marrow and blood. It is sometimes fatal and frequently arises from leukemic genes.

Anonymous Patient Answer

Have there been any new discoveries for treating leukemia?

No breakthroughs in treatment have been found in all aspects of leukemia since 1960. Many drugs have come into use and shown promise in the treatment of acute leukemia. The development of targeted and personalized therapies for leukemias have shown promise in the treatment of chronic myeloid leukemia, whereas the first new drug for the treatment of acute lymphoblastic leukaemia for many years is lenalidomide. There have been some advances in treatment. For patients with chronic myeloid leukaemia, and chronic lymphocytic leukaemia, the treatment of choice has been consolidation therapy, combining several drugs with different mechanisms of action on different blood cell types.

Anonymous Patient Answer

What is the average age someone gets leukemia?

For the entire time period 1985-2013, the 5-year survival rates for patients with acute leukemia were 77% and 67% in patients who had leukemia <56 years old and ≥56 years old, respectively.

Anonymous Patient Answer

Have there been other clinical trials involving questionnaires?

There seem to be two distinct areas of methodological quality in medical research. There is either an absence or an inadequate number of trials that actually use questionnaires to evaluate participants, or alternatively the methodology can be described as poor. We consider that the questionnaire should be used in further clinical studies, especially the quality of life assessment, in cancer care. One should consider the use of the Quality of Life Questionnaire in clinical trials so as to help to evaluate the quality of care.

Anonymous Patient Answer

What are the chances of developing leukemia?

When a person is diagnosed with leukemia, the risk of secondary cancer is approximately one-third. It is difficult to definitively make an honest estimation of the risk, as this depends on many factors, including age at diagnosis, sex, type of diagnosis, lifestyle, and time interval between diagnoses of leukemia and second cancers.\n

Anonymous Patient Answer

Does leukemia run in families?

It is very likely that a high proportion of leukemia cases has an inherited genetic component. Inherited cancer predisposition may be attributable to mutated DNA, or it may in turn be due to environmental risk factors, such as lifestyle. Genetic predisposition may be more pronounced than environmental risk factors in sporadic or juvenile forms of leukemia.

Anonymous Patient Answer
See if you qualify for this trial
Get access to this novel treatment for Leukemia by sharing your contact details with the study coordinator.